Your browser doesn't support javascript.
loading
Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia.
Lyski, Zoe L; Kim, Myung S; Xthona Lee, David; Raué, Hans-Peter; Raghunathan, Vikram; Griffin, Janet; Ryan, Debbie; Brunton, Amanda E; Curlin, Marcel E; Slifka, Mark K; Messer, William B; Spurgeon, Stephen E.
Afiliação
  • Lyski ZL; Department of Molecular Microbiology and Immunology and.
  • Kim MS; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.
  • Xthona Lee D; Department of Molecular Microbiology and Immunology and.
  • Raué HP; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR.
  • Raghunathan V; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.
  • Griffin J; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.
  • Ryan D; Knight Cancer Institute, Oregon Health & Science University, Portland, OR.
  • Brunton AE; Oregon Health & Science University-Portland State University School of Public Health, Portland, OR; and.
  • Curlin ME; Division of Infectious Diseases, Department of Medicine, Oregon Health & Science University, Portland, OR.
  • Slifka MK; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR.
  • Messer WB; Department of Molecular Microbiology and Immunology and.
  • Spurgeon SE; Oregon Health & Science University-Portland State University School of Public Health, Portland, OR; and.
Blood Adv ; 6(4): 1207-1211, 2022 02 22.
Article em En | MEDLINE | ID: mdl-34872103

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / COVID-19 Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / COVID-19 Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article